-
Medicure Announces Launch of New and Improved ReDS™ PRO
Tuesday, September 17, 2019
View article
-
Medicure Announces Settlement of Patent Infringement Action
Wednesday, August 21, 2019
View article
-
Medicure Reports Financial Results for Quarter Ended June 30, 2019
Thursday, August 8, 2019
View article
-
Medicure Q2 2019 Results and Conference Call Dates
Friday, August 2, 2019
View article
-
Medicure Announces Results of 2019 Annual Meeting of Shareholders
Wednesday, June 26, 2019
View article
-
Medicure Announces Appoinment of Dr. Neil Owens as President and Chief Operating Officer
Monday, June 10, 2019
View article
-
Medicure Announces Renewal of its Normal Course Issuer Bid
Thursday, May 30, 2019
View article
-
Medicure Reports Financial Results for Quarter Ended March 31, 2019
Monday, May 27, 2019
View article
-
Medicure Q1 2019 Results and Conference Call Dates
Wednesday, May 22, 2019
View article
-
Medicure Appoints Ms. Manon Harvey to its Board of Directors
Wednesday, May 15, 2019
View article
-
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2018
Monday, April 29, 2019
View article
-
Medicure to Announce Fiscal Year End 2018 Financial Results on April 29, 2019
Wednesday, April 24, 2019
View article
-
Medicure Provides Update on Release of Holdback Funds from Apicore Sale
Wednesday, February 13, 2019
View article
-
Medicure Announces Agreement to Market ReDS™ Device for Congestive Heart Failure Patients in the United States
Monday, January 28, 2019
View article
-
Medicure reports financial results for quarter ended September 30, 2018
Tuesday, November 20, 2018
View article
-
Medicure Files Patent Infringement Action
Friday, November 16, 2018
View article
-
Medicure Q3 2018 Results and Conference Call Dates
Wednesday, November 14, 2018
View article
-
Medicure Reports Financial Results for Quarter Ended June 30, 2018
Wednesday, August 15, 2018
View article
-
Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection
Monday, August 13, 2018
View article
-
Medicure Q2 2018 Results and Conference Call Dates
Wednesday, August 8, 2018
View article
-
Medicure Reports Financial Results for Quarter Ended March 31, 2018
Wednesday, May 23, 2018
View article
-
Medicure Q1 2018 Results and Conference Call Dates
Thursday, May 17, 2018
View article
-
Medicure Announces Normal Course Issuer Bid
Thursday, May 17, 2018
View article
-
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2017
Tuesday, May 1, 2018
View article
-
Medicure announces availability of ZYPITAMAG™ (pitavastatin) in the U.S.
Tuesday, May 1, 2018
View article
-
Medicure to Announce Fiscal Year End 2017 Financial Results on April 30, 2018
Tuesday, April 24, 2018
View article
-
Medicure Announces Further Up-Date on PREXXARTAN®
Wednesday, March 28, 2018
View article
-
Medicure Announces an Up-Date on PREXXARTAN® Launch
Monday, March 19, 2018
View article
-
Zydus partners with Medicure to launch its NDA Product, ZYPITAMAG (pitavastatin) in the U.S.
Wednesday, March 7, 2018
View article
-
Medicure Announces Receipt of Deferred Proceeds from Apicore Sale
Thursday, February 1, 2018
View article
-
Medicure Announces FDA Approval Received for Prexxartan®
Tuesday, December 19, 2017
View article
-
Medicure Acquires Exclusive License to Sell and Market Branded Cardiovascular Drug in the U.S.
Thursday, December 14, 2017
View article
-
Medicure Reports Financial Results for Quarter Ended September 30, 2017
Tuesday, November 21, 2017
View article
-
Medicure Announces Repayment of Outstanding Debt
Friday, November 17, 2017
View article
-
Medicure Q3 Results and Conference Call Dates
Wednesday, November 15, 2017
View article
-
Medicure Acquires Exclusive License to Sell and Market PREXXARTAN® in the U.S. from Carmel Biosciences
Tuesday, October 31, 2017
View article
-
Medicure Announces Sale of Apicore Business
Tuesday, October 3, 2017
View article
-
Medicure Reports Financial Results for Quarter Ended June 30, 2017
Monday, August 7, 2017
View article
-
Medicure Q2 Results and Conference Call Dates
Wednesday, August 2, 2017
View article
-
Medicure Closes Acquisition of Additional Interests in Apicore
Wednesday, July 12, 2017
View article
-
Medicure Exercises Option to Acquire Additional Interests in Apicore
Monday, July 10, 2017
View article
-
Medicure Provides Update on Apicore Purchase Option
Monday, July 3, 2017
View article
-
Medicure Reports Financial Results for Quarter Ended March 31, 2017
Wednesday, May 24, 2017
View article
-
Medicure Q1 Results and Conference Call Dates
Thursday, May 18, 2017
View article
-
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2016
Wednesday, April 26, 2017
View article
-
Medicure to Announce Fiscal Year End 2016 Financial Results on April 26, 2017
Wednesday, March 29, 2017
View article
-
Medicure Announces FDA Approval for Apicore's Generic Tetrabenazine
Thursday, March 23, 2017
View article
-
Medicure Provides Apicore Secured Loan to Replace Knight Loan
Monday, January 9, 2017
View article
-
Medicure announces filing of ANDA in collaboration with Apicore
Tuesday, December 13, 2016
View article
-
Medicure Closes Acquisition of Majority Interest in Apicore
Thursday, December 1, 2016
View article
